A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage IV|Unresectable Locally Advanced Invasive Breast Cancer|Metastatic Invasive Breast Cancer
Interventions: DRUG: Palbociclib|DRUG: Bazedoxifene
Sponsor: Dana-Farber Cancer Institute
Collaborators: Pfizer